The only stem cell therapy that currently should be accepted in the role of therapy of multiple sclerosis outside of clinical trials is autologous hematopoietic stem cell transplantation (HSCT), for which there is a lot/a lot/quite a lot interesting details about possible benefits, risks and side effects of [url=http://blogs.coventry.ac.uk/researchblog/we-know-how-food-production-needs-to-change-if-crisis-is-to-be-avoided-so-why-isnt-this-happening/blogheaderagrocoleogy/]http://blogs.coventry.ac.uk/researchblog/we-know-how-food-production-needs-to-change-if-crisis-is-to-be-avoided-so-why-isnt-this-happening/blogheaderagrocoleogy/[/url].